Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism cyp3a cyp450'

Search results for: 'research area metabolism cyp3a cyp450'

Items 21-30 of 47

Page
per page
  1. GSK3787
    A4303 GSK3787
    Summary: PPARβ/δ antagonist,novel and irreversible
      insoluble in H2O; ≥15.8 mg/mL
  2. Rosiglitazone
    A4304 Rosiglitazone
    Summary: Potent PPARγ agonist
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  3. Ketoconazole
    A4316 Ketoconazole
    Target: Cytochrome P450 (CYP450)
    Summary: Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase
      ≥23.4 mg/mL
  4. Apremilast (CC-10004)
    A4317 Apremilast (CC-10004)
    Target: Phosphodiesterases (PDEs)
    Summary: PDE4 inhibitor
      ≥23.05 mg/mL
  5. Tadalafil
    A4327 Tadalafil
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
  6. S- (+)-Rolipram
    A4349 S- (+)-Rolipram
    Summary: CAMP-specific PDE4 inhibitor
      insoluble in H2O; ≥13.9 mg/mL
  7. Varespladib (LY315920)
    A4356 Varespladib (LY315920)
    Target: Phospholipases
    Summary: HnsPLA inhibitor,potent and selective
  8. Ferrostatin-1 (Fer-1)
    A4371 Ferrostatin-1 (Fer-1)
    Target: Ferroptosis
    Summary: Ferroptosis inhibitor, erastin-induced
      ≥149 mg/mL
  9. Anacetrapib (MK-0859)
    A4375 Anacetrapib (MK-0859)
     1 Citation
    Target: CETP
    Summary: RhCETP/mutant CETP(C13S) inhibitor
      ≥31.9 mg/mL
  10. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: CETP inhibitor,potent and selective
      ≥32.1 mg/mL

Items 21-30 of 47

Page
per page